# Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population

> **NCT00307528** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 146 (actual)

## Conditions studied

- Prophylaxis Invasive Pneumococcal Diseases and Pneumonia

## Interventions

- **BIOLOGICAL:** Pneumococcal vaccine GSK513026
- **BIOLOGICAL:** Pneumovax 23™

## Key facts

- **NCT ID:** NCT00307528
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01-20
- **Primary completion:** 2005-03-30
- **Final completion:** 2005-03-30
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2019-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00307528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00307528, "Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00307528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*